O28: The health economics of gBRCA screening in high-risk breast cancer: How gBRCA became fully reimbursable in a middle-income country*

Documenti analoghi

• O28: The health economics of gBRCA screening in high-risk breast cancer: How gBRCA became fully reimbursable in a middle-income country*
  di: Pongtawat Lertwilaiwittaya, et al.
  Pubblicazione: (2023-01-01)
• P621: The health economics of Lynch syndrome screening in colorectal cancer: When genetic testing is cost-saving in a middle-income country
  di: Pongtawat Lertwilaiwittaya, et al.
  Pubblicazione: (2025-01-01)
• P069: Progressive neurological symptoms in a 36-year-old female: Clinical challenge
  di: Farah Salman, et al.
  Pubblicazione: (2025-01-01)
• P736: Constitutional mosaic pericentromeric trisomy 8 in a female patient with aplastic anemia
  di: Min Gao, et al.
  Pubblicazione: (2024-01-01)
• P087: Response to ketone therapy in an unusual case of type 1 multiple Acyl-CoA dehydrogenase deficiency
  di: Grace Raines, et al.
  Pubblicazione: (2025-01-01)